Page last updated: 2024-08-23

sq-11725 and amibegron

sq-11725 has been researched along with amibegron in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdeaux, A; Bévérelli, F; Gauthier, C; Le Marec, H; Leblais, V; Rautureau, Y; Trochu, JN1
Balligand, JL; Donckier, JE; Gauthier, C; Heyndrickx, GR; Massart, PE; Van Mechelen, H1
Erfanian, M; Gauthier, C; Heymann, MF; Langin, D; Laurent, K; Tavernier, G; Toumaniantz, G1
Audigane, L; Cantereau, A; Charpentier, F; El Harchi, A; Gauthier, C; Kerfant, BG; Lorenzen-Schmidt, I; Noireaud, J; Potreau, D; Toumaniantz, G1

Other Studies

4 other study(ies) available for sq-11725 and amibegron

ArticleYear
Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
    British journal of pharmacology, 1999, Volume: 128, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Nadolol; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Vasoconstriction; Vasodilation

1999
Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
    European journal of clinical investigation, 2001, Volume: 31, Issue:8

    Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atropine Derivatives; Blood Pressure; Bupranolol; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hexamethonium; Hypertension, Renal; Lipolysis; Myocardial Contraction; Nadolol; Propanolamines; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Time Factors

2001
beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
    Cardiovascular research, 2003, Aug-01, Volume: 59, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Bupranolol; Cyclic GMP; Depression, Chemical; Dioxoles; Electrocardiography; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Nadolol; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes

2003
Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.
    Experimental physiology, 2009, Volume: 94, Issue:4

    Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amino Acid Sequence; Animals; Base Sequence; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Ventricles; Humans; Isoproterenol; Male; Models, Animal; Molecular Sequence Data; Myocardial Contraction; Myocytes, Cardiac; Nadolol; Nitric Oxide; Rabbits; Rats; Receptors, Adrenergic, beta-3; RNA, Messenger; Tetrahydronaphthalenes; Time Factors

2009